Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income countries26. September 2025
Health ArcaScience Raises $7M to Advance AI-Powered Drug Benefit-Risk EvaluationHealthradar4. September 2025 What You Should Know: – ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led…
